Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.22), $0.03 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.4 million versus the consensus estimate of $18.33 million.

Veracyte reiterates its 2017 annual revenue guidance of $76 to $84 million and annual cash burn of $25 to $27 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.